Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2145 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.750 | 1.000 | 5 | 2011 | 2019 | |||||
Malignant neoplasm of breast
|
2154 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.750 | 1.000 | 5 | 2011 | 2019 | |||||
Thyroid carcinoma
|
116 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.720 | 1.000 | 2 | 2016 | 2019 | |||||
Glioblastoma
|
157 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.710 | 1.000 | 1 | 2015 | 2018 | |||||
Glioblastoma Multiforme
|
160 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.710 | 1.000 | 1 | 2015 | 2018 | |||||
ovarian neoplasm
|
229 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.710 | 1.000 | 1 | 2016 | 2017 | |||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
203 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.030 | 1.000 | 3 | 2016 | 2019 | |||||
Renal Cell Carcinoma
|
182 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.030 | 1.000 | 3 | 2016 | 2019 | |||||
estrogen receptor-negative breast cancer
|
40 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2011 | 2016 | |||||
Malignant neoplasm of ovary
|
246 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||
Malignant neoplasm of thyroid
|
103 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||
Malignant Neoplasms
|
1441 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||
Papillary thyroid carcinoma
|
193 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2019 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||
Thyroid Neoplasm
|
114 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||
Adult type dermatomyositis
|
31 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Carcinoma of lung
|
995 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Carcinoma, Ovarian Epithelial
|
321 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Childhood Acute Lymphoblastic Leukemia
|
259 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Chronic Obstructive Airway Disease
|
301 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Clear-cell metastatic renal cell carcinoma
|
11 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Complete atrioventricular block
|
95 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Coronary heart disease
|
769 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Dermatomyositis
|
33 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Diabetes Mellitus
|
714 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2015 | 2015 |